Patel Mahesh V.

CIK 00015798721 companySALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001579872

Recent Transactions

50 trades

Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2026-01-02$8.00/sh+25,000→ 182,668 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2025-12-18$4.20/sh+8,629→ 157,668 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2025-01-02$4.86/sh+16,371→ 149,039 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2024-12-23$4.80/sh+26,691→ 149,039 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2024-12-23$4.80/sh+10,320→ 132,688 total
Award
Lipocine Inc.$LPCN
Common Stock
2024-03-08+4,893→ 112,311 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2023-05-25$5.03/sh+8,706→ 107,418 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2023-03-24$0.32/sh+150,000→ 1,678,090 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2023-03-17$0.33/sh+50,000→ 1,528,090 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2023-01-03$0.41/sh+300,000→ 2,542,395 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2022-12-22$0.41/sh+112,500→ 2,242,395 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2022-11-14$0.39/sh+75,000→ 1,478,090 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2022-09-27$0.41/sh+100,000→ 1,403,090 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2022-05-16$0.77/sh+50,000→ 1,303,090 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2022-01-03$1.09/sh+287,500→ 287,500 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2021-12-07$1.12/sh+125,000→ 125,000 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2021-11-18$1.09/sh+25,000→ 1,253,090 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2021-01-04$1.43/sh+275,000→ 275,000 total
Other
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2020-12-28−275,000→ 100,000 total
Exercise/Conversion
Lipocine Inc.$LPCN
Common Stock
2020-12-16+45,000→ 1,243,090 total
Exercise/Conversion
Lipocine Inc.$LPCN
Restricted Stock Unit
2020-12-16+45,000→ 45,000 total
Sale
Lipocine Inc.$LPCN
Common Stock
2020-12-16$1.35/sh−15,000→ 1,228,090 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2020-12-15$1.37/sh+375,000→ 375,000 total
Exercise/Conversion
Lipocine Inc.$LPCN
Common Stock
2020-12-05+122,978→ 1,198,090 total
Exercise/Conversion
Lipocine Inc.$LPCN
Restricted Stock Unit
2020-12-05−122,978→ 122,978 total
Sale
Lipocine Inc.$LPCN
Common Stock
2020-12-04$1.57/sh−43,500→ 1,075,112 total
Exercise/Conversion
Lipocine Inc.$LPCN
Restricted Stock Unit
2020-12-04−145,000→ 145,000 total
Exercise/Conversion
Lipocine Inc.$LPCN
Common Stock
2020-12-04+145,000→ 1,118,612 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2020-01-28$0.46/sh+300,000→ 300,000 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2019-12-31$0.38/sh+40,000→ 973,612 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2019-12-10$0.40/sh+25,000→ 933,612 total
Award
Lipocine Inc.$LPCN
Restricted Stock Unit
2019-12-05+122,978→ 122,978 total
Exercise/Conversion
Lipocine Inc.$LPCN
Restricted Stock Unit
2019-12-04−145,000→ 145,000 total
Sale
Lipocine Inc.$LPCN
Common Stock
2019-12-04$0.41/sh−43,500→ 908,612 total
Exercise/Conversion
Lipocine Inc.$LPCN
Common Stock
2019-12-04+145,000→ 952,112 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2019-11-26$0.43/sh+1,272→ 783,384 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2019-11-26$0.43/sh+21,928→ 807,112 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2019-11-26$0.43/sh+1,100→ 785,184 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2019-11-26$0.43/sh+700→ 784,084 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2019-11-18$0.40/sh+40,259→ 777,302 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2019-11-18$0.40/sh+4,931→ 737,043 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2019-11-18$0.42/sh+4,810→ 782,112 total
Award
Lipocine Inc.$LPCN
Common Stock
2019-05-24$1.64/sh+2,500→ 732,112 total
Award
Lipocine Inc.$LPCN
Common Stock
2019-05-24$1.59/sh+2,500→ 729,139 total
Award
Lipocine Inc.$LPCN
Common Stock
2019-05-24$1.58/sh+4,527→ 726,639 total
Award
Lipocine Inc.$LPCN
Common Stock
2019-05-24$1.60/sh+473→ 729,612 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2018-12-04$1.46/sh+150,000→ 150,000 total
Award
Lipocine Inc.$LPCN
Restricted stock unit
2018-12-04+290,000→ 290,000 total
Exercise/Conversion
Lipocine Inc.$LPCN
Common Stock
2017-12-29+15,000→ 728,112 total
Exercise/Conversion
Lipocine Inc.$LPCN
Restricted Stock Unit
2017-12-29−15,000→ 45,000 total

Patel Mahesh V.

Recent Transactions

Companies

Recent Filings

Address